TY  - GEN
AU  - Corona, Diana
AU  - Pérez-Valero, Ignacio
AU  - Camacho, Angela
AU  - Gutiérrez Liarte, Ángela
AU  - Montero-Alonso, Marta
AU  - Alemán, María Remedios
AU  - Ruiz-Seco, Pilar
AU  - Pérez González, Alexandre
AU  - Riera, Melchor
AU  - Jarrin-Vera, Inmaculada
AU  - Rivero-Juárez, Antonio
AU  - Rivero, Antonio
PY  - 2024
DO  - 10.1016/j.ijantimicag.2023.107016
UR  - http://hdl.handle.net/20.500.12105/18995
AB  - Objectives: The efficacy of BIC/FTC/TAF in HIV late presenters initiating antiretroviral therapy (ART) has not been sufficiently evaluated. Methods: The aim of this study was to assess the effectiveness and tolerability of BIC/FTC/TAF compared to...
LA  - eng
PB  - Elsevier
KW  - Advance HIV disease
KW  - BIC/FTC/TAF
KW  - ART initiation
KW  - Naïve
KW  - Anti-HIV Agents
KW  - Acquired Immunodeficiency Syndrome
KW  - HIV Infections
KW  - Piperazines
KW  - Pyridones
KW  - Alanine
KW  - Amides
KW  - Heterocyclic Compounds, 3-Ring
KW  - Adult
KW  - Male
KW  - Humans
KW  - Female
KW  - Drug Combinations
KW  - Emtricitabine
KW  - Tenofovir
TI  - Effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in HIV late presenters
TY  - research article
ER  -